Tekla Healthcare Investors (HQH)

US — Financial Services Sector
Peers: THQ  ETO  THW  LDP  HQL  RNP  XFLT  DFP  UTF  RMT  NIE  RQI  FOF 

Automate Your Wheel Strategy on HQH

With Tiblio's Option Bot, you can configure your own wheel strategy including HQH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HQH
  • Rev/Share 0.2008
  • Book/Share 19.7557
  • PB 0.7795
  • Debt/Equity 0.0
  • CurrentRatio 0.4329
  • ROIC -0.0002

 

  • MktCap 829477880.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE 4.466
  • Debt/Assets 0.0
  • DivYield 0.1506
  • ROE 0.1789

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

HQH: Efficient Fund To Collect Income From Healthcare
HQH
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Positive

I maintain my buy rating on HQH for its high 13.6% yield, strong dividend coverage, and efficient healthcare sector diversification. HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines. The fund is well-positioned to benefit from long-term healthcare sector growth, driven by rising spending and health-conscious trends.

Read More
image for news HQH: Efficient Fund To Collect Income From Healthcare
HQH: A Good Balance Of Returns And Risks In The Healthcare Sector
HQH
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Neutral

HQH offers a compelling mix of high yield and growth exposure to healthcare, trading at a discount to NAV with recent outperformance versus benchmarks. The fund benefits from strong healthcare industry tailwinds—aging populations and innovation—while active management and share buybacks support narrowing the NAV discount. A robust 13.6% market yield and a fair value estimate 36% above current price highlight significant upside, though distribution sustainability must be monitored.

Read More
image for news HQH: A Good Balance Of Returns And Risks In The Healthcare Sector
8 Closed-End Fund Buys (And 2 Sells) In The Month Of March 2025
BDJ, BME, BOE, BSTZ, CII, DMA, ECAT, GDV, HQH, QQQX, THQ
Published: April 14, 2025 by: Seeking Alpha
Sentiment: Positive

This month we got some increased market volatility, allowing me to put some of my cash pile to work in my closed-end fund portfolio. I also sold out of two positions, as they were starting to become on the more expensive side in terms of discounts/premiums. Adding to my positions regularly every month increases my cash flow annually, and even every month it grows.

Read More
image for news 8 Closed-End Fund Buys (And 2 Sells) In The Month Of March 2025
Bargain Alert: 2 Big Dividends, Up To 10% Yield
HQH, NNN, THQ
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Positive

Immunize your retirement from market noise with recurring dividends. We discuss two essential sectors for reliable income generation, regardless of economic conditions. Discover our top picks with up to 10% yields.

Read More
image for news Bargain Alert: 2 Big Dividends, Up To 10% Yield
I Am Loading Up Big Dividends For My Golden Years
HQH, HROW
Published: February 17, 2025 by: Seeking Alpha
Sentiment: Positive

Innovation, demand, and shortage of providers have kept healthcare inflation significantly higher than the CPI. Regardless of the political scene, the aging U.S. population and rising chronic illnesses are undeniable truths to face. Income investing ensures consistent returns, allowing flexibility in financial planning, despite volatile stock prices.

Read More
image for news I Am Loading Up Big Dividends For My Golden Years
HQH: Improved Fundamentals, Strong Dividend Support
HQH
Published: February 09, 2025 by: Seeking Alpha
Sentiment: Positive

HQH offers a high dividend yield of 13.6%, making it attractive for income-focused investors, despite potential tax consequences. The fund trades at a 7.86% discount to NAV, presenting a good entry point, especially with anticipated interest rate cuts and increased healthcare spending. HQH's portfolio is heavily concentrated in Biotechnology (64.6%), posing sector-specific risks but also benefiting from projected growth in biotech and healthcare spending.

Read More
image for news HQH: Improved Fundamentals, Strong Dividend Support

About Tekla Healthcare Investors (HQH)

  • IPO Date 1987-04-23
  • Website https://www.teklacap.com/hqh.html
  • Industry Asset Management
  • CEO Dr. Daniel R. Omstead M.S, Ph.D.
  • Employees None
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.